Delta Air Lines, Inc. (DAL) Stock Price Today
Aura AI Summary
Key Stats
- $49.10BMarket Cap
- 5,547,797Volume
- IndustrialsSector
- $93.6652W High
- $55.6552W Low
- 98 DaysTypical Hold Time
- $64.15BEnterprise Value
- 1.15%Div Yield
- 99% Sell | 1% BuyTrading Activity
Track Delta Air Lines, Inc. (DAL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Delta Air Lines, Inc. has traded between a low of $55.65 and a high of $93.66, highlighting its annual price range. Buy and sell Delta Air Lines, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Delta Air Lines, Inc.
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.
Most Recent News
Global EV components market to hit $1.28 trillion by 2036, driven by battery tech and power electronics
The global electric vehicle (EV) components market is projected to grow from $486.4 billion in 2026 to $1.28 trillion by 2036, expanding at a 10.2% CAGR. Growth is fueled by rising EV adoption, advancements in battery systems, power electronics, and ...

Alternative Ballistics secures new U.S. and Abu Dhabi orders, expanding less-lethal product reach.
Alternative Ballistics Corporation announced new purchase orders from U.S. online retailer Botach and a distributor in Abu Dhabi. Botach placed an initial order for The Home Defense™, marking its first online wholesale deal and expanding U.S. distrib...

Aclarion reports 85% scan volume growth in Q3 2026 and advances CLARITY trial with strong cash position.
Aclarion, Inc. announced an 85% year-over-year increase in scan volumes for Q3 2026, contributing to a 117% growth for the first nine months of the year. The company highlighted the publication of supportive clinical data in the European Spine Journa...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.